These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24940801)

  • 21. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
    Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
    Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational profiles of medullary myofibroblasts during kidney fibrosis.
    Grgic I; Krautzberger AM; Hofmeister A; Lalli M; DiRocco DP; Fleig SV; Liu J; Duffield JS; McMahon AP; Aronow B; Humphreys BD
    J Am Soc Nephrol; 2014 Sep; 25(9):1979-90. PubMed ID: 24652793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteostasis as a therapeutic target in glomerular injury associated with mutant α-actinin-4.
    Yee A; Papillon J; Guillemette J; Kaufman DR; Kennedy CRJ; Cybulsky AV
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F954-F966. PubMed ID: 29873512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis.
    Zhuang Q; Li F; Liu J; Wang H; Tian Y; Zhang Z; Wang F; Zhao Z; Chen J; Wu H
    Lab Invest; 2021 Feb; 101(2):258-270. PubMed ID: 33203894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
    Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
    Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Podocyte injury at young age causes premature senescence and worsens glomerular aging.
    Veloso Pereira BM; Zeng Y; Maggiore JC; Schweickart RA; Eng DG; Kaverina N; McKinzie SR; Chang A; Loretz CJ; Thieme K; Hukriede NA; Pippin JW; Wessely O; Shankland SJ
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F120-F134. PubMed ID: 37855038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Mutation of Coenzyme Q
    Song CC; Hong Q; Geng XD; Wang X; Wang SQ; Cui SY; Guo MD; Li O; Cai GY; Chen XM; Wu D
    Chin Med J (Engl); 2018 Nov; 131(22):2666-2675. PubMed ID: 30425193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
    Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
    Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
    Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
    J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
    Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
    J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-actinin-4 and CLP36 protein deficiencies contribute to podocyte defects in multiple human glomerulopathies.
    Liu Z; Blattner SM; Tu Y; Tisherman R; Wang JH; Rastaldi MP; Kretzler M; Wu C
    J Biol Chem; 2011 Sep; 286(35):30795-30805. PubMed ID: 21680739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.
    Chan GC; Eng DG; Miner JH; Alpers CE; Hudkins K; Chang A; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1680-F1694. PubMed ID: 31630546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis.
    Matoba K; Nagai Y; Sekiguchi K; Ohashi S; Mitsuyoshi E; Shimoda M; Tachibana T; Kawanami D; Yokota T; Utsunomiya K; Nishimura R
    Commun Biol; 2024 Apr; 7(1):402. PubMed ID: 38565675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury.
    Henderson JM; Alexander MP; Pollak MR
    J Am Soc Nephrol; 2009 May; 20(5):961-8. PubMed ID: 19357256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphologic Analysis of Urinary Podocytes in Focal Segmental Glomerulosclerosis.
    Shirai Y; Miura K; Yokoyama T; Horita S; Nakayama H; Seino H; Ando T; Shiratori A; Yabuuchi T; Kaneko N; Ishiwa S; Ishizuka K; Hara M; Hattori M
    Kidney360; 2021 Mar; 2(3):477-486. PubMed ID: 35369007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Focal segmental glomerulosclerosis; why does it occur segmentally?
    Nagata M; Kobayashi N; Hara S
    Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
    Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
    FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.